A PHYSICIANS GUIDE TO INFORMATION AVAILABLE FROM THE FDA ABOUT NEW DRUG APPROVALS

被引:0
|
作者
HASSALL, TH
FREDD, SB
机构
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 1989年 / 84卷 / 10期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1222 / 1226
页数:5
相关论文
共 50 条
  • [41] FDA new drug approvals in Q3 2019
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (11) : 816 - 816
  • [42] Breast cancer drug approvals by the US FDA from 1949 to 2018
    Leo, Chandra P.
    Leo, Cornelia
    Szucs, Thomas D.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (01) : 11 - 11
  • [43] An updated analysis of new oncologic drug approvals at FDA by expedited program.
    Pulte, Dianne
    Kanapuru, Bindu
    Shea, Michael
    Farrell, Ann T.
    Blumenthal, Gideon Michael
    Allen, Jeff
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] MARKET WATCH FDA new drug approvals in Q2 2019
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (08) : 575 - 575
  • [45] MARKET WATCH FDA new drug approvals in Q2 2022
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (08) : 550 - 550
  • [46] MARKET WATCH FDA new drug approvals in Q2 2021
    Urquhart, Lisa
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (08) : 578 - 578
  • [47] The economic consequences of US FDA new drug approvals: evidence from Taiwan pharmaceutical and biotech companies
    Chen, Yong-Jie
    Feng, Zhi-Yuan
    Li, Yueh-Ping
    Huang, Hua-Wei
    INNOVATION-ORGANIZATION & MANAGEMENT, 2021, 23 (03): : 354 - 374
  • [48] Update on nutritional supplements - Information available from the FDA
    不详
    EXERCISE STANDARDS AND MALPRACTICE REPORTER, 2001, 15 (01): : 15 - 15
  • [49] Recent drug approvals from the US FDA and EMEA: what the future holds
    Pevarello, Paolo
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (01) : 35 - 48
  • [50] FDA's decisions in oncology drug product approvals from 2006 to 2016
    Hyogo, Atsushi
    Kaneko, Masayuki
    Narukawa, Mamoru
    HEALTH POLICY AND TECHNOLOGY, 2018, 7 (04) : 341 - 346